GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » PB Ratio

Blau Farmaceutica (BSP:BLAU3) PB Ratio

: 0.92 (As of Today)
View and export this data going back to 2021. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Blau Farmaceutica's share price is R$10.35. Blau Farmaceutica's Book Value per Share for the quarter that ended in Dec. 2023 was R$11.26. Hence, Blau Farmaceutica's PB Ratio of today is 0.92.

Good Sign:

Blau Farmaceutica SA stock PB Ratio (=0.91) is close to 3-year low of 0.91

The historical rank and industry rank for Blau Farmaceutica's PB Ratio or its related term are showing as below:

BSP:BLAU3' s PB Ratio Range Over the Past 10 Years
Min: 0.91   Med: 2.79   Max: 27.76
Current: 0.92

During the past 8 years, Blau Farmaceutica's highest PB Ratio was 27.76. The lowest was 0.91. And the median was 2.79.

BSP:BLAU3's PB Ratio is ranked better than
80.87% of 962 companies
in the Drug Manufacturers industry
Industry Median: 1.91 vs BSP:BLAU3: 0.92

During the past 12 months, Blau Farmaceutica's average Book Value Per Share Growth Rate was 9.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 107.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 70.20% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Blau Farmaceutica was 107.40% per year. The lowest was 17.00% per year. And the median was 89.10% per year.

Back to Basics: PB Ratio


Blau Farmaceutica PB Ratio Historical Data

The historical data trend for Blau Farmaceutica's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Premium Member Only Premium Member Only Premium Member Only - - 3.99 2.57 1.46

Blau Farmaceutica Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.57 2.33 1.76 1.44 1.46

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blau Farmaceutica PB Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's PB Ratio distribution charts can be found below:

* The bar in red indicates where Blau Farmaceutica's PB Ratio falls into.



Blau Farmaceutica PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Blau Farmaceutica's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=10.35/11.264
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Blau Farmaceutica  (BSP:BLAU3) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Blau Farmaceutica PB Ratio Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Blau Farmaceutica (BSP:BLAU3) Business Description

Traded in Other Exchanges
N/A
Address
Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica (BSP:BLAU3) Headlines

No Headlines